Cloverfields Capital Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18,857
Closed -$2.64M 98
2025
Q2
$2.64M Buy
18,857
+1,050
+6% +$147K 0.78% 55
2025
Q1
$2.62M Sell
17,807
-60
-0.3% -$8.68K 0.86% 47
2024
Q4
$2.34M Buy
17,867
+1,600
+10% +$224K 0.75% 48
2024
Q3
$2.53M Sell
16,267
-2,750
-14% -$444K 0.82% 49
2024
Q2
$2.97M Buy
19,017
+170
+0.9% +$25.6K 1% 45
2024
Q1
$2.55M Buy
18,847
+213
+1% +$28.2K 0.86% 46
2023
Q4
$2.51M Buy
18,634
+5,938
+47% +$772K 0.98% 43
2023
Q3
$1.72M Hold
12,696
0.77% 51
2023
Q2
$1.82M Buy
12,696
+5,220
+70% +$768K 0.59% 51
2023
Q1
$1.04M Buy
7,476
+3,454
+86% +$465K 0.31% 57
2022
Q4
$545K Hold
4,022
0.17% 52
2022
Q3
$441K Hold
4,022
0.15% 53
2022
Q2
$531K Sell
4,022
-1,942
-33% -$255K 0.16% 50
2022
Q1
$791K Sell
5,964
-659
-10% -$79K 0.25% 45
2021
Q4
$772K Hold
6,623
0.24% 47
2021
Q3
$795K Buy
6,623
+31
+0.5% +$3.61K 0.26% 46
2021
Q2
$790K Buy
6,592
+74
+1% +$8.12K 0.23% 45
2021
Q1
$648K Buy
6,518
+138
+2% +$13.9K 0.21% 48
2020
Q4
$638K Buy
+6,380
New +$676K 0.24% 45

Other funds holding AZN